Samsung Biologics To Acquire GSK's Rockville Facility For US$280 Mln
(RTTNews) - Samsung Biologics (207940.KS) announced that its wholly owned U.S. subsidiary, Samsung Biologics America, will acquire 100% of Human Genome Sciences from GSK (GSK, GSK.L) for US$280...
Nasdaq News: Markets·5d ago